Diseases & Disorders
(G99)
990 on File
WASHINGTON INSTITUTE FOR COAGULATION
Financial strength (30%)
64/100
Reliability (20%)
45/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$114.5M
Total Revenue
$104.4M
Total Expenses
$40.4M
Net Assets
45
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
97.7%
Fundraising Efficiency
N/A
Operating Reserve
4.65x
Liability-to-Asset
45.6%
Revenue Diversification
99.4%
Executive Compensation
$422K
Compared with Peers
FY 2023
Compared with 42 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
97.7% | 86.7% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
2.3% | 9.1% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.1% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
4.7 mo | 5.3 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
45.6% | 42.3% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.4% | 95.2% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
114.4% | 1.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
110.8% | 10.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
8.8% | 0.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $114.5M | $104.4M | $40.4M | 97.7% | 45 |
| 2022 | $53.4M | $49.5M | $30.3M | 96.3% | 0 |
| 2021 | $109.4M | $95.8M | N/A | — | 36 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.